CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (905) 475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- 424B5 Offering Prospectus
- 4 Open-market sale Director sold 7,992 shares at $7.25 ($57,942)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Other events
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Option exercise Director acquired 1,218 shares (option exercise)
- 4 Option exercise Director acquired 4,262 shares (option exercise)
- 4 Option exercise President acquired 914 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 609 shares (option exercise)
- 4 Option exercise Director acquired 1,218 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 4,628 shares (option exercise)
- 4 Option exercise Director acquired 609 shares (option exercise)
- 4 Option exercise Director acquired 70,314 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 17 of 38 · 753 filings